BofA and TD Cowen have both raised their price targets and reiterated Buy ratings for Fortinet, Inc. (FTNT), citing strong demand, growth opportunities in SASE and related markets, and the potential for AI to drive further growth. The company, a cybersecurity provider, holds over 20% of the firewall market share, benefiting from ongoing data center buildouts. While Fortinet is seen as a profitable software stock, the article also suggests exploring other AI stocks with potentially higher and faster returns.

Ball Corp. (ISIN US05722G1004) shares are closely tied to the beverage-packaging cycle, with investors monitoring demand, costs, and margins. The company's performance is influenced by its ability to offset aluminum costs and factory utilization with steady beverage demand and contract pricing. Analysts typically focus on operating leverage, free cash flow, debt reduction, and revenue growth within the context of broader manufacturing and retail trends.

Old Dominion Freight Line (ODFL) is prioritizing reliable less-than-truckload (LTL) service and disciplined cost control amidst a fluctuating freight market. The company operates by consolidating smaller shipments through a dense network of terminals, emphasizing operational efficiency, and using technology to optimize its services. ODFL positions itself as a premium LTL provider, focusing on network density, technology investments, and a diversified customer base to navigate economic shifts and maintain pricing discipline.

The FDA has approved an expansion for Vertex Pharmaceuticals’ gene therapy Casgevy, allowing its use in children aged 2 years and up with sickle cell disease and transfusion-dependent beta thalassemia. This marks Casgevy as the first genetic medicine for these indications available to young children and was expedited via the Commissioner’s National Priority Voucher program. While initially approved for patients 12 and older, this new approval opens the treatment to approximately 5,500 additional U.S. patients, despite initial slow uptake with the therapy generating $43 million in the first quarter.

This article compiles ten top analyst rating changes for various companies, including Amazon.com (AMZN). Wells Fargo boosted Amazon's price target to $313, maintaining an Overweight rating, with Amazon shares closing at $241.70. Other analyst updates include changes for Robinhood, Westlake, Genmab, Levi Strauss, Generac Holdings, General Mills, PepsiCo, Palantir Technologies, and Alaska Air Group.

Travelers Companies, a prominent US property-casualty insurer, is navigating changes in the insurance landscape by emphasizing underwriting discipline, meticulous risk selection, and maintaining strong capital. The company's strategy involves carefully evaluating risks, setting appropriate premiums, and avoiding aggressive growth to ensure consistent profitability. Travelers is considered a bellwether for insurance trends, with its performance reflecting broader economic activity and influencing the financial sector for US retail investors and analysts.

Hologic, Inc. is recalling its BioZorb Marker due to a significant number of reported complications and adverse events, including pain, infection, and device migration, though no deaths have occurred. The implantable radiographic marker, used to identify soft tissues like breast tissue for medical procedures, consists of both permanent titanium and resorbable plastic components. The recall comes after 252 reported injuries were linked to the device.

ONEOK Inc. operates a significant midstream natural gas network in the United States, offering investors fee-based pipeline and storage assets that generate stable cash flows and dividend income. The company's business model centers on gathering, processing, transporting, and storing natural gas and natural gas liquids, providing critical infrastructure that supports various sectors and aims for resilience against commodity price fluctuations. ONEOK's strategy involves network expansion, asset optimization, and maintaining strong customer relationships, while its investment appeal lies in steady cash generation, measured leverage, and consistent dividend payments.

AFLAC Inc. is highlighted as a major supplemental insurance provider with a business model focused on consistent policy growth and sound capital management, operating primarily in the U.S. and Japan. The company emphasizes financial discipline, product specialization, and widespread distribution networks, positioning itself for long-term stability amidst rising healthcare costs and demographic shifts. Aflac's strategy includes value creation through policy growth, underwriting margins, investment income, and returning capital to shareholders via dividends and share repurchases.

Zacks Research has lowered its Q2 2028 earnings per share estimate for Devon Energy (NYSE: DVN) from $1.05 to $1.02, maintaining a "Hold" rating on the stock. Despite this cautious outlook, many analysts still recommend Devon Energy as a "Moderate Buy." The company recently raised its quarterly dividend to $0.32 per share, yielding 3.2% annually, even after its last quarterly results missed revenue and EPS expectations.